rare diseases – Benefits Canada.com https://www.benefitscanada.com Canada's most influential pension and benefits publication for decision-makers Fri, 26 Apr 2024 20:02:31 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.8 Top 5 HR, benefits, pension and investment stories of the week https://www.benefitscanada.com/news/bencan/top-5-hr-benefits-pension-and-investment-stories-of-the-week-71/ Fri, 02 Feb 2024 14:00:43 +0000 https://www.benefitscanada.com/?p=151473 An article on the Canadian Life and Health Insurance Association’s priorities for the coming year was the most-read story on BenefitsCanada.com this past week. Here are the top five human resources, benefits, pension and investment stories of the week: 1. CLHIA focusing on improving pharmacare, rare disease drug coverage in 2024 2. Majority of Canadian employers expecting […]

The post Top 5 HR, benefits, pension and investment stories of the week appeared first on Benefits Canada.com.

]]> CLHIA focusing on improving pharmacare, rare disease drug coverage in 2024 https://www.benefitscanada.com/benefits/health-benefits/clhia-focusing-on-improving-pharmacare-rare-disease-drug-coverage-in-2024/ Mon, 29 Jan 2024 14:00:29 +0000 https://www.benefitscanada.com/?p=151208 In the year ahead, the Canadian Life and Health Insurance Association will continue its advocacy efforts to ensure the federal government’s proposed pharmacare plan extends coverage for those who lack benefits without disrupting workplace benefits that millions of working Canadians rely on, says Stephen Frank, the association’s president and chief executive officer. The right approach to […]

The post CLHIA focusing on improving pharmacare, rare disease drug coverage in 2024 appeared first on Benefits Canada.com.

]]> High-cost drug claims lead to 20-times greater cost per claim for small plan sponsors https://www.benefitscanada.com/events/conference-coverage/high-cost-drug-claims-lead-to-20-times-greater-cost-per-claim-for-small-plan-sponsors/ Mon, 22 Jan 2024 13:00:24 +0000 https://www.benefitscanada.com/?p=150385 A recent survey by Innovative Medicines Canada found there are growing listing delays among Canada’s private drug plans, said Joe Farago, the organization’s executive director of private payers and investment, during a session at Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in December. The survey noted private payer review times can take […]

The post High-cost drug claims lead to 20-times greater cost per claim for small plan sponsors appeared first on Benefits Canada.com.

]]> Innovative drugs helping plan members manage chronic conditions https://www.benefitscanada.com/events/conference-coverage/innovative-drugs-helping-plan-members-manage-chronic-conditions/ Mon, 22 Jan 2024 12:59:56 +0000 https://www.benefitscanada.com/?p=150359 Many plan members with diabetes struggle with adherence to daily insulin injections and research has found the majority of patients wish they could achieve the same control over their condition with fewer injections, said Jacob Bonafiglia, medical science liaison with Novo Nordisk Canada Inc., during a panel discussion sponsored by Boehringer-Ingelheim Canada, Merck Canada Inc. […]

The post Innovative drugs helping plan members manage chronic conditions appeared first on Benefits Canada.com.

]]> How preferred pharmacy networks can lower drug plan costs, boost access to care https://www.benefitscanada.com/events/conference-coverage/how-preferred-pharmacy-networks-can-lower-drug-plan-costs-boost-access-to-care/ Mon, 22 Jan 2024 12:58:55 +0000 https://www.benefitscanada.com/?p=150509 Pharmacists are now uniquely positioned to support Canadians at a time when the public health-care system is stretched thin, creating significant barriers for people looking to access care, said Dr. Jennifer Poh, senior director of drug plan solutions at Health Solutions by Shoppers, during Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in […]

The post How preferred pharmacy networks can lower drug plan costs, boost access to care appeared first on Benefits Canada.com.

]]> Plan sponsors, private payers can work together to help employees with rare diseases access novel treatments https://www.benefitscanada.com/events/conference-coverage/employees-with-rare-diseases-need-help-from-plan-sponsors-private-payers-to-access-novel-treatments-patient-advocate/ Mon, 22 Jan 2024 12:53:19 +0000 https://www.benefitscanada.com/?p=150657 It’s important for private payers and employers to be nimble and innovative to support plan members seeking access to novel drugs and treatments by addressing common hurdles within their own drug plans, said John Adams, chair of the board of directors for patient advocacy group Best Medicines Coalition, during a session at Benefits Canada’s 2023 Face […]

The post Plan sponsors, private payers can work together to help employees with rare diseases access novel treatments appeared first on Benefits Canada.com.

]]> Top 5 HR, benefits, pension and investment stories of the week https://www.benefitscanada.com/news/bencan/top-5-hr-benefits-pension-and-investment-stories-of-the-week-68/ Fri, 12 Jan 2024 14:00:44 +0000 https://www.benefitscanada.com/?p=150279 A story on mental-health themes and challenges for 2024 was the most-read story on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investment stories of the past week: 1. Expert panel: Employers taking preventative, holistic approach to employee mental health in 2024 2. AI holds uncapped potential for pension plan sponsors’ administration, communications: […]

The post Top 5 HR, benefits, pension and investment stories of the week appeared first on Benefits Canada.com.

]]> Highest-cost drugs reimbursed by Canadian public plans in 2021/22 were rare disease treatments: report https://www.benefitscanada.com/benefits/health-benefits/highest-cost-drugs-reimbursed-by-canadian-public-plans-in-2021-22-were-rare-disease-treatments-report/ Tue, 09 Jan 2024 14:00:15 +0000 https://www.benefitscanada.com/?p=149971 The 10 highest-cost drugs reimbursed by public drug plans in Canada in the 2021/22 fiscal year were all rare disease treatments with annual treatment costs of more than $250,000, according to a new report by the Patented Medicine Prices Review Board. It found the increased use of high-cost drugs continued to be the main factor […]

The post Highest-cost drugs reimbursed by Canadian public plans in 2021/22 were rare disease treatments: report appeared first on Benefits Canada.com.

]]> Feds name advisory group for national strategy for drugs for rare diseases https://www.benefitscanada.com/notice/appointment-notice/feds-names-advisory-group-for-national-strategy-for-drugs-for-rare-diseases/ Fri, 03 Nov 2023 13:00:31 +0000 https://www.benefitscanada.com/?p=146375 The federal government is appointing members to an implementation advisory group to support the launch of its national strategy for drugs for rare diseases. The members from Canada’s private payer community include: Stephen Frank, president and chief executive officer of the Canadian Life and Health Insurance Association; Joanne Jung, Canadian pharmacy and clinical practice leader at […]

The post Feds name advisory group for national strategy for drugs for rare diseases appeared first on Benefits Canada.com.

]]> Survey finds 60% of plan sponsors reporting increased health benefits costs https://www.benefitscanada.com/benefits/health-benefits/survey-finds-60-of-plan-sponsors-reporting-increased-health-benefits-costs/ Mon, 25 Sep 2023 13:00:12 +0000 https://www.benefitscanada.com/?p=143682 Three-fifths (60 per cent) of benefits plan sponsors say the costs of their health benefits plan increased in the past three years, according to the 2023 Benefits Canada Healthcare Survey. It found this percentage decreased from 66 per cent when the question was last asked in 2016 and was unchanged from 2015 (60 per cent). […]

The post Survey finds 60% of plan sponsors reporting increased health benefits costs appeared first on Benefits Canada.com.

]]>